Initial studies found that MSI2 was required for the initiation and maintenance of BCR-ABL (CML-BC)27 driven myeloid leukemia and forced expression drove a more aggressive form of CML in mice. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.